Cell therapies for traumatic brain injury - PubMed (original) (raw)

Review

Cell therapies for traumatic brain injury

Matthew T Harting et al. Neurosurg Focus. 2008.

Abstract

Preliminary discoveries of the efficacy of cell therapy are currently being translated to clinical trials. Whereas a significant amount of work has been focused on cell therapy applications for a wide array of diseases, including cardiac disease, bone disease, hepatic disease, and cancer, there continues to be extraordinary anticipation that stem cells will advance the current therapeutic regimen for acute neurological disease. Traumatic brain injury is a devastating event for which current therapies are limited. In this report the authors discuss the current status of using adult stem cells to treat traumatic brain injury, including the basic cell types and potential mechanisms of action, preclinical data, and the initiation of clinical trials.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

Light microscopic image showing MSCs grown in vitro after isolation from bone marrow and several passages.

Fig. 2

Fig. 2

Left: Light microscopic image demonstrating NSCs (arrows) grown in vitro after isolation from the subventricular zone. Right: Light microscopic image showing a magnified view of the NSCs as groups of cells called neurospheres.

Fig. 3

Fig. 3

Protocol for enrollment, cell infusion, and follow-up in a Phase I clinical trial assessing the safety of autologous bone marrow cells in children after TBI. ARDS = acute respiratory distress syndrome; BM = bone marrow; BMT = BM transplantation; CAGT = The Center for Cell and Gene Therapy; DTMR = diffusion tensor magnetic resonance (imaging); GOS = Glascow Outcome Scale; Neuro = neuropsychiatric testing.

Similar articles

Cited by

References

    1. Al Nimer F, Wennersten A, Holmin S, Meijer X, Wahlberg L, Mathiesen T. MHC expression after human neural stem cell transplantation to brain contused rats. Neuroreport. 2004;15:1871–1875. - PubMed
    1. Anonymous: Consensus conference. Rehabilitation of persons with traumatic brain injury. NIH Consensus Development Panel on Rehabilitation of Persons With Traumatic Brain Injury. JAMA. 1999;282:974–983. - PubMed
    1. Bakshi A, Shimizu S, Keck CA, Cho S, LeBold DG, Morales D, et al. Neural progenitor cells engineered to secrete GDNF show enhanced survival, neuronal differentiation and improve cognitive function following traumatic brain injury. Eur J Neurosci. 2006;23:2119–2134. - PubMed
    1. Boockvar JA, Schouten J, Royo N, Millard M, Spangler Z, Castelbuono D, et al. Experimental traumatic brain injury modulates the survival, migration, and terminal phenotype of transplanted epidermal growth factor receptor-activated neural stem cells. Neurosurgery. 2005;56:163–171. - PubMed
    1. Borlongan CV, Hadman M, Sanberg CD, Sanberg PR. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke. 2004;35:2385–2389. - PubMed

Publication types

MeSH terms

LinkOut - more resources